Last summer GCMI attended MD&M East in New York where additive manufacturing was a key focus (these were our takeaways) – now, we are headed to Anaheim, California to see what MD&M West has in store. Not only is MD&M a great opportunity to reconnect with long time partners and innovators on the west coast,…
“Atlanta is a rich community for healthcare leaders and innovative thinkers.” Through the lens of Atlanta’s medtech innovation ecosystem, GCMI and T3 Labs CEO Tiffany Wilson recently spoke with Sky Magazine about the resources available to medical device innovators and startups in Atlanta. Many of GCMI and T3 Labs partners and sponsors were highlighted in…
We want to begin by wishing you and your team, a joyous and safe holiday season. Thank you for all your support and the opportunities you have sent our way. We hope you all get to enjoy this time with your loved ones. In so many ways, 2017 was a landmark year for GCMI. From…
Michael Fisher, Director of Product Development for GCMI, shares his insights from the IEEE-NIH Healthcare Innovations and Point of Care Technology conference. Recently, GCMI attended and spearheaded a presentation during the IEEE-NIH Healthcare Innovations and Point of Care Technology conference which focuses on innovation and technologies for precision health and their clinical translation, to address…
Medical technology innovators learn quickly that there is little, if any, flexibility in the FDA approval process. NFANT Labs knew they needed multidisciplinary partners able to build flexibility into an inflexible process, designing and developing their product with a constant eye on efficiency and the FDA approval prize. In the United States, up to 70%…
The MedTech Conference, AdvaMed’s flagship event, is the leading medtech industry conference in North America. September 25 – 27 in San Jose will find thousands of medtech industry leaders gathered together in a multifaceted environment for business development, capital formation, technology showcasing, world-class educational opportunities and networking at AdvaMed 2017. Tiffany Wilson, CEO of GCMI…
The Medtech Women at SEMDA (MW@S) Advisory Board has announced the finalists for the inaugural class of the Top 10 Women in Southeast Medtech.
GCMI’s Director of Product Development, Mike Fisher, recently spoke about the ins and outs of successful medical device development as a guest on Greenlight Guru’s Global Medical Device Podcast. “A good rule of thumb for innovators is that your product, your prototype, or your idea should lead the conversation but right behind it needs to…
With preclinical help from T3 Labs and the support of experts within the Atlanta medtech ecosystem, Dr. Rebecca Levit and her team is revolutionizing drug delivery for Atrial Fibrillation. Dr. Levit is Assistant Professor of Cardiology at Emory University in Atlanta, GA and adjunct faculty in the Department of Biomedical Engineering at the Georgia Institute…
Announced recently via the Georgia Tech News Center, Microneedle Patches for flu vaccination were found safe to use following a successful human clinical trial. “Despite the potentially severe consequences of illness and even death, only about 40 percent of adults in the United States receive flu shots each year,” writes Holly Korschun, Director, Research Communications…